rs377767373
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_005359.6(SMAD4):c.1549_1550delAG(p.Ser517HisfsTer9) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005359.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMAD4 | NM_005359.6 | c.1549_1550delAG | p.Ser517HisfsTer9 | frameshift_variant | Exon 12 of 12 | ENST00000342988.8 | NP_005350.1 | |
SMAD4 | NM_001407041.1 | c.1549_1550delAG | p.Ser517HisfsTer9 | frameshift_variant | Exon 12 of 12 | NP_001393970.1 | ||
SMAD4 | NM_001407042.1 | c.1549_1550delAG | p.Ser517HisfsTer9 | frameshift_variant | Exon 12 of 12 | NP_001393971.1 | ||
SMAD4 | NR_176265.1 | n.2200_2201delAG | non_coding_transcript_exon_variant | Exon 13 of 13 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This deletion of two nucleotides in SMAD4 is denoted c.1549_1550delAG at the cDNA level and p.Ser517HisfsX9 (S517HfsX9) at the protein level. The normal sequence, with the bases that are deleted in brackets, is ACAG[delAG]CATC. The deletion causes a frameshift which changes a Serine to a Histidine at codon 517, and creates a premature stop codon at position 9 of the new reading frame. This variant is predicted to cause loss of normal protein function through protein truncation. SMAD4 Ser517HisfsX9, also known as c.(1546-1548)CAGfs using alternate nomenclature, has not, to our knowledge, been published in the literature as a germline variant; however, it has been reported as a somatic variant in a pancreatic tumor (Witkiewicz 2015). Based on the currently available information, we consider this deletion to be a likely pathogenic variant. -
The SMAD4 c.1549_1550del (p.Ser517Hisfs*9) variant alters the translational reading frame of the SMAD4 mRNA and is predicted to cause the premature termination of SMAD4 protein synthesis. This variant has not been reported in individuals with SMAD4-related conditions in the published literature. However, it has been reported as a somatic variant in a pancreatic tumor (PMID: 25855536 (2015)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as likely pathogenic. -
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome Pathogenic:2
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
- -
Hereditary cancer-predisposing syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
The c.1549_1550delAG pathogenic mutation, located in coding exon 11 of the SMAD4 gene, results from a deletion of two nucleotides at nucleotide positions 1549 to 1550, causing a translational frameshift with a predicted alternate stop codon (p.S517Hfs*9). This alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation. -
Juvenile polyposis syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ser517Hisfs*9) in the SMAD4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 36 amino acid(s) of the SMAD4 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMAD4-related conditions. ClinVar contains an entry for this variant (Variation ID: 545806). This variant disrupts a region of the SMAD4 protein in which other variant(s) (p.Ala532Profs*5) have been determined to be pathogenic (PMID: 15031030). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at